The Role of Ischemia-Modified Albumin and Ischemia-Modified Albumin to Albumin Ratios in Patients with Alopecia Areata

    January 2023 in “ Dermatology Practical & Conceptual ”
    Efsun TanaCan, Aynure Oztekın, Ünsal Savcı … Erel Özcan
    Studysummary In this study, the researchers reported that ischemia-modified albumin and IMA/albumin levels may not effectively predict disease severity in patients with alopecia areata.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on dpcj.org →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Ischemia-Modified Albumin as a New Biomarker in Predicting Oxidative Stress in Alopecia Areata Turkish journal of medical sciences · 2019
    2. Alopecia Areata: A Multifactorial Autoimmune Condition Journal of autoimmunity · 2018
    3. Alopecia Areata: A Review of Disease Pathogenesis British journal of dermatology/British journal of dermatology, Supplement · 2018
    4. Alopecia Areata: Overview and Insights from January 2018 Journal of The American Academy of Dermatology · 2017
    5. Cardiovascular Risk in Patients with Alopecia Areata: A Propensity-Matched Retrospective Analysis Journal of the American Academy of Dermatology · 2016
    6. Alopecia Areata Increases the Risk of Stroke: A 3-Year Follow-Up Study Scientific Reports · 2015
    7. Antioxidants and Lipid Peroxidation Status in the Blood of Patients with Alopecia Cell biochemistry and function · 2000

    Related research 1

    1. The Role of Ischemia-Modified Albumin and Ischemia-Modified Albumin to Albumin Ratios in Patients with Alopecia Areata Dermatology Practical & Conceptual · 2023